- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Automatic Translation feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
NF-κB as a therapeutic drug target
-
- HISHIKAWA Keiichi
- Department of Pharmacology, Teikyo University, School of Medicine
-
- NAKAKI Toshio
- Department of Pharmacology, Teikyo University, School of Medicine
Bibliographic Information
- Other Title
-
- 薬の標的としての転写因子NF-κB
- クスリ ノ ヒョウテキ ト シテ ノ テンシャ インシ NF カッパ B
- NF-κB as a therapeutic drug target
Search this article
Description
The transcription factor NF-κB has attracted widespread interest based on its unusual regulation, the variety of stimuli that activate it, the diverse genes and biological responses that it controls, the striking evolutionary conservation of structure and function among family members, and its apparent involvement in a variety of human diseases. Recently NF-κB has been shown to be the target of new drug discovery. Here, we discuss the so-called NF-κB inhibitors and consider the development of new therapeutic agents.
Journal
-
- Folia Pharmacologica Japonica
-
Folia Pharmacologica Japonica 118 (3), 197-202, 2001
The Japanese Pharmacological Society
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390282679249321216
-
- NII Article ID
- 10007943448
-
- NII Book ID
- AN00198335
-
- COI
- 1:CAS:528:DC%2BD3MXms1Kksbs%3D
-
- ISSN
- 13478397
- 00155691
-
- NDL BIB ID
- 5890656
-
- PubMed
- 11577460
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed